Craft

OXGENE

Revenue

£1 M

FY, 2018

OXGENE Summary

Company Summary

Overview
OXGENE (also known as Oxford Genetics) is a synthetic biology company. It specializes in DNA design, protein expression optimization, and cell line development. The company offers plasmid products with DNA sections that are inserted into the same plasmid backbone, including CRISPR, reporter gene, peptide and protein tag, peptide tag cleavage, secretion signal, promoter type, and other DNA plasmids.
Type
Subsidiary
Status
Active
Founded
2011
HQ
Oxford, GB | view all locations
Website
https://oxgene.com/
Cybersecurity rating
Sectors

Key People

  • David Chang

    David Chang, Chief Executive Officer, Wuxi Advanced Therapies

    • Martin Hall

      Martin Hall, Finance Director

      • David Hames

        David Hames, Non-Executive Chairman

      • Leonard Seymour

        Leonard Seymour, Founding Scientist & Non-Executive Director

      LocationsView all

      1 location detected

      • Oxford, England HQ

        United Kingdom

        Robert Robinson Ave

      OXGENE Financials

      Summary Financials

      Revenue (FY, 2018)
      £1.0M
      Gross profit (FY, 2018)
      £736.3K
      Net income (FY, 2018)
      (£2.7M)
      Cash (FY, 2018)
      £3.4M
      EBIT (FY, 2018)
      (£3.0M)

      Footer menu